Cancellation of state registration. Visken®

April 10, 2018
Active substances:
Trade names:
ICD-10:
II.D10-D36.D35.0    Benign neoplasm of the adrenal gland
V.F40-F48.F45.3    Somatoform dysfunction of the autonomic nervous system
IX.I10-I15.I10    Essential [primary] hypertension
IX.I20-I25.I20    Angina pectoris [angina pectoris]
IX.I30-I52.I42    Cardiomyopathy
IX.I30-I52.I47.1    Nadzheludochkovaya tachycardia
IX.I30-I52.I48    Atrial fibrillation and flutter
IX.I30-I52.I49.3    Premature depolarization of the ventricles
IX.I30-I52.I49.1    Premature depolarization of the atria
Vineyard, pindolol, prophylaxis of angina pectoris, arterial hypertension, extrasystoles, cardiomyopathy

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines", decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N013238 / 01 from August 17, 2007, JSC "Pharmaceutical Plant EGIS", Hungary) was issued:

Visken® (trade name of the medicinal product)

Pindolol (international non-patented or batch or chemical name)

tablets, 5 mg (dosage form, dosage)

ZAO "Pharmaceutical Plant EGIS", Hungary 1165 Budabest, Bokenyfoldi ut 118-120, Hungary (name and address of the location of the manufacturer of the medicinal product)

on the basis of the application by the authorized legal entity of the Representative Office of ZAO "Pharmaceutical Plant EGIS" to cancel the state registration of the medicinal product.